{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:40:56Z","timestamp":1793176856834,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13346-023-01334-7","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T13:02:42Z","timestamp":1680786162000},"page":"2503-2519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid\u2013base neutralization approach"],"prefix":"10.1007","volume":"13","author":[{"given":"Mahendra","family":"Chougule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Sirvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanshul","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay T.","family":"Sangamwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"1334_CR1","unstructured":"European Medicines Agency (EMA). Assessment report for Tasigna (nilotinib) procedure No.: EMEA\/H\/C\/000798\/X\/0028. 2010. p. 41."},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1021\/mp2001022","volume":"8","author":"S Shukla","year":"2011","unstructured":"Shukla S, Skoumbourdis AP, Walsh MJ, Hartz AMS, Fung KL, Wu C, et al. Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Mol Pharm. 2011;8:1292\u2013302.","journal-title":"Mol Pharm"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/ejh.13418","volume":"105","author":"CCLM Boons","year":"2020","unstructured":"Boons CCLM, den Hartog YM, Janssen JJWM, Zandvliet AS, Vos RM, Swart EL, et al. Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): enabling dose reduction and relief of treatment burden. Eur J Haematol. 2020;105:148\u201355.","journal-title":"Eur J Haematol"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.1158\/0008-5472.CAN-08-1008","volume":"68","author":"FX Mahon","year":"2008","unstructured":"Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, et al. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Can Res. 2008;68:9809\u201316.","journal-title":"Can Res"},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s11095-013-1191-4","volume":"31","author":"G Jesson","year":"2014","unstructured":"Jesson G, Brisander M, Andersson P, Demirb\u00fcker M, Derand H, Lennern\u00e4s H, et al. Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors. AAPS Pharm Res. 2014;31:694\u2013705.","journal-title":"AAPS Pharm Res"},{"key":"1334_CR6","doi-asserted-by":"crossref","unstructured":"Koehl NJ, Holm R, Kuentz M, Griffin BT. New insights into using lipid based suspensions for \u2018Brick Dust\u2019 molecules\u202f: case study of nilotinib. AAPS Pharm Res. 2019;36.","DOI":"10.1007\/s11095-019-2590-y"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"F Kesisoglou","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y. Nanosizing - oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631\u201344.","journal-title":"Adv Drug Deliv Rev"},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijpharm.2012.09.020","volume":"438","author":"Y Xu","year":"2012","unstructured":"Xu Y, Liu X, Lian R, Zheng S, Yin Z, Lu Y, et al. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation\/homogenization based on acid-base neutralization. Int J Pharm. 2012;438:287\u201395.","journal-title":"Int J Pharm"},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijpharm.2011.04.034","volume":"413","author":"D Mou","year":"2011","unstructured":"Mou D, Chen H, Wan J, Xu H, Yang X. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm. 2011;413:237\u201344.","journal-title":"Int J Pharm"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijpharm.2016.03.056","volume":"505","author":"Y Wang","year":"2016","unstructured":"Wang Y, Han X, Wang J, Wang Y. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method. Int J Pharm. 2016;505:35\u201341.","journal-title":"Int J Pharm"},{"key":"1334_CR11","first-page":"757","volume":"14","author":"G Shen","year":"2016","unstructured":"Shen G, Cheng L, Wang LQ, Zhang LH, De SB, Liao WB, et al. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability. Chin J Nat Med. 2016;14:757\u201368.","journal-title":"Chin J Nat Med"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejpb.2020.07.001","volume":"154","author":"H Van Ngo","year":"2020","unstructured":"Van Ngo H, Park C, Tran TTD, Nguyen VH, Lee BJ. Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs. Eur J Pharm Biopharm. 2020;154:8\u201317.","journal-title":"Eur J Pharm Biopharm"},{"key":"1334_CR13","doi-asserted-by":"crossref","unstructured":"Thakore SD, Sirvi A, Joshi VC, Panigrahi SS, Manna A, Singh R, et al. Biorelevant dissolution testing and physiologically based absorption modeling to predict in vivo performance of supersaturating drug delivery systems. Int J Pharm. Elsevier B.V.; 2021;607:120958.","DOI":"10.1016\/j.ijpharm.2021.120958"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/2230-973X.138344","volume":"4","author":"K Thadkala","year":"2014","unstructured":"Thadkala K, Nanam PK, Rambabu B, Sailu C, Aukunuru J. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability. Int J Pharm Investig. 2014;4:131\u20137.","journal-title":"Int J Pharm Investig"},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.powtec.2012.12.038","volume":"237","author":"RN Shamma","year":"2013","unstructured":"Shamma RN, Basha M. Soluplus\u00ae\u00a0: a novel polymeric solubilizer for optimization of carvedilol solid dispersions\u202f: formulation design and effect of method of preparation. Powder Technol. 2013;237:406\u201314.","journal-title":"Powder Technol"},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpharm.2014.10.025","volume":"477","author":"H Yang","year":"2014","unstructured":"Yang H, Teng F, Wang P, Tian B, Lin X, Hu X, et al. Investigation of a nanosuspension stabilized by Soluplus to improve bioavailability. Int J Pharm. 2014;477:88\u201395.","journal-title":"Int J Pharm"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/aps.2016.126","volume":"38","author":"Y Zeng","year":"2017","unstructured":"Zeng Y, Li S, Liu C, Gong T, Sun X, Fu Y, et al. Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo. Acta Pharmacol Sin. 2017;38:424\u201333.","journal-title":"Acta Pharmacol Sin"},{"key":"1334_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1081\/DDC-120027506","volume":"30","author":"Y Nishiyama","year":"2004","unstructured":"Nishiyama Y, Kokubo H. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm. 2004;30:9\u201317.","journal-title":"Drug Dev Ind Pharm"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1208\/s12249-014-0269-6","volume":"16","author":"SM Alshahrani","year":"2015","unstructured":"Alshahrani SM, Lu W, Park J, Morott JT, Alsulays BB, Majumdar S, et al. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus\u00ae\u00a0and HPMCAS-HF. AAPS PharmSciTech. 2015;16:824\u201334.","journal-title":"AAPS PharmSciTech"},{"key":"1334_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","volume":"46","author":"E Baka","year":"2008","unstructured":"Baka E, Comer JEA, Tak K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335\u201341.","journal-title":"J Pharm Biomed Anal"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jpba.2013.05.011","volume":"83","author":"K Tak\u00e1cs-Nov\u00e1k","year":"2013","unstructured":"Tak\u00e1cs-Nov\u00e1k K, Sz\u0151ke V, V\u00f6lgyi G, Horv\u00e1th P, Ambrus R, Szab\u00f3-R\u00e9v\u00e9sz P. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid. J Pharm Biomed Anal. 2013;83:279\u201385.","journal-title":"J Pharm Biomed Anal"},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1208\/s12248-015-9825-6","volume":"17","author":"DD Sun","year":"2015","unstructured":"Sun DD, Lee PI. Commentary haste makes waste\u202f: the interplay between dissolution and precipitation of supersaturating formulations. AAPS J. 2015;17:1317\u201326.","journal-title":"AAPS J"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1208\/s12249-018-1189-7","volume":"19","author":"BY Gajera","year":"2018","unstructured":"Gajera BY, Shah DA, Dave RH. Investigating a novel hot melt extrusion-based drying technique to solidify an amorphous nanosuspension using design of experiment methodology. AAPS PharmSciTech. 2018;19:3778\u201390.","journal-title":"AAPS PharmSciTech"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","volume":"47","author":"RH M\u00fcller","year":"2001","unstructured":"M\u00fcller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47:3\u201319.","journal-title":"Adv Drug Deliv Rev"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1208\/s12249-014-0267-8","volume":"16","author":"R Gadadare","year":"2014","unstructured":"Gadadare R, Mandpe L, Pokharkar V. Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom- up and top-down approach\u202f: influence of food on pharmacokinetics behavior. AAPS PharmSciTech. 2014;16:787\u201399.","journal-title":"AAPS PharmSciTech"},{"key":"1334_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2009.05.006","volume":"377","author":"S Verma","year":"2009","unstructured":"Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377:185\u201398.","journal-title":"Int J Pharm"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.powtec.2016.09.004","volume":"302","author":"OP Sharma","year":"2016","unstructured":"Sharma OP, Patel V, Mehta T. Design of experiment approach in development of febuxostat nanocrystal\u202f: application of Soluplus\u00ae\u00a0as stabilizer. Powder Technol. 2016;302:396\u2013405.","journal-title":"Powder Technol"},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"115828","DOI":"10.1016\/j.carbpol.2020.115828","volume":"233","author":"S Sarabu","year":"2020","unstructured":"Sarabu S, Kallakunta VR, Bandari S, Batra A, Bi V, Durig T, et al. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: effect of drug physicochemical properties. Carbohyd Polym. 2020;233:115828.","journal-title":"Carbohyd Polym"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.18433\/J3530J","volume":"13","author":"Y Liu","year":"2010","unstructured":"Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci. 2010;13:589\u2013606.","journal-title":"J Pharm Pharm Sci"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2014.08.017","volume":"474","author":"TT Tran","year":"2014","unstructured":"Tran TT, Tran PH, Ngoc M, Nguyen U, Thi K, Tran M, et al. Amorphous isradipine nanosuspension by the sonoprecipitation method. Int J Pharm. 2014;474:146\u201350.","journal-title":"Int J Pharm"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1248\/cpb.c15-00655","volume":"64","author":"S Tanida","year":"2016","unstructured":"Tanida S, Kurokawa T, Sato H, Kadota K, Tozuka Y. Evaluation of the micellization mechanism of an amphipathic graft copolymer with enhanced solubility of ipriflavone. Chem Pharm Bull. 2016;64:68\u201372.","journal-title":"Chem Pharm Bull"},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1021\/jp013639d","volume":"106","author":"Y Won","year":"2002","unstructured":"Won Y, Brannan AK, Davis HT, Bates FS. Cryogenic transmission electron microscopy (Cryo-TEM) of micelles and vesicles formed in water by poly(ethylene oxide)-based block copolymers. J Phys Chem B. 2002;106:3354\u201364.","journal-title":"J Phys Chem B"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/1567201813666160902152122","volume":"14","author":"Y Xie","year":"2017","unstructured":"Xie Y, Chen Z, Su R, Li Y, Qi J, Wu W, et al. Preparation and optimization of amorphous ursodeoxycholic acid nano - suspensions by nanoprecipitation based on acid-base neutralization for enhanced dissolution. Curr Drug Deliv. 2017;14:483\u201391.","journal-title":"Curr Drug Deliv"},{"key":"1334_CR34","doi-asserted-by":"crossref","unstructured":"Singh A, Bharati A, Frederiks P, Verkinderen O, Goderis B, Cardinaels R, Van den Mooter G.\u00a0Effect of compression on the molecular arrangement of itraconazole\u2013soluplus solid dispersions: Induction of liquid crystals or exacerbation of phase separation?. Mol Pharm. 2016;13(6):1879\u20131893.","DOI":"10.1021\/acs.molpharmaceut.6b00046"},{"key":"1334_CR35","unstructured":"Lan Y, Ali S, Langley N. Characterization of Soluplus by FTIR and Raman Spectroscopy. BASF Corporation, Pharma Ingredients and Services: Tarrytown, NY, USA. 2010."},{"key":"1334_CR36","doi-asserted-by":"crossref","unstructured":"Jha DK, Shah DS, Amin PD. Effect of hypromellose acetate succinate substituents on miscibility behavior of spray-dried amorphous solid dispersions\u202f: Flory \u2013 Huggins parameter prediction and validation. Carbohydr Polym Technol Appl. Elsevier Ltd; 2021;2:100137.","DOI":"10.1016\/j.carpta.2021.100137"},{"key":"1334_CR37","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.jddst.2021.103038","volume":"68","author":"S Zhu","year":"2022","unstructured":"Zhu S, Yu R, Qian G, Deng L. A supersaturating drug delivery system to enhance the oral bioavailability of nilotinib. J Drug Deliv Sci Technol. 2022;68:103038.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1334_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ijpharm.2017.07.010","volume":"529","author":"M Herbrink","year":"2017","unstructured":"Herbrink M, Schellens JHM, Beijnen JH, Nuijen B. Improving the solubility of nilotinib through novel spray-dried solid dispersions. Int J Pharm. 2017;529:294\u2013302.","journal-title":"Int J Pharm"},{"key":"1334_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejpb.2010.01.011","volume":"75","author":"W Yang","year":"2010","unstructured":"Yang W, Johnston KP, Williams RO. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm. 2010;75:33\u201341.","journal-title":"Eur J Pharm Biopharm"},{"key":"1334_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1208\/s12249-018-1216-8","volume":"20","author":"X Xue","year":"2019","unstructured":"Xue X, Chen G, Xu X, Wang J, Wang J, Ren L. A combined utilization of Plasdone-S630 and HPMCAS-HF in ziprasidone hydrochloride solid dispersion by hot-melt extrusion to enhance the oral bioavailability and no food effect. AAPS PharmSciTech. 2019;20:37.","journal-title":"AAPS PharmSciTech"},{"key":"1334_CR41","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1007\/s11095-011-0505-7","volume":"28","author":"AG Thombre","year":"2011","unstructured":"Thombre AG, Herbig SM, Alderman JA. Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect. Pharm Res. 2011;28:3159\u201370.","journal-title":"Pharm Res"},{"key":"1334_CR42","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/jps.24426","volume":"104","author":"SB Murdande","year":"2015","unstructured":"Murdande SB, Shah DA, Dave RH. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals. J Pharm Sci. 2015;104:2094\u2013102.","journal-title":"J Pharm Sci"},{"key":"1334_CR43","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1208\/s12248-016-9972-4","volume":"18","author":"AZX Zhu","year":"2016","unstructured":"Zhu AZX, Ho MD, Gemski CK, Chuang B, Liao M, Xia CQ. Utilizing in vitro dissolution-permeation chamber for the quantitative prediction of pH-dependent drug-drug interactions with acid-reducing agents\u202f: a comparison with physiologically based pharmacokinetic modeling. AAPS J. 2016;18:1512\u201323.","journal-title":"AAPS J"},{"key":"1334_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ijpharm.2012.10.025","volume":"441","author":"S Hu","year":"2013","unstructured":"Hu S, Niu M, Hu F, Lu Y, Qi J, Yin Z, et al. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Int J Pharm. 2013;441:693\u2013700.","journal-title":"Int J Pharm"},{"key":"1334_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.14227\/DT260219P6","volume":"26","author":"L Klumpp","year":"2019","unstructured":"Klumpp L, Nagasekar K, McCullough O, Seybert A, Ashtikar M, Dressman J. Stability of biorelevant media under various storage conditions. Dissolution Technol. 2019;26:6\u201318.","journal-title":"Dissolution Technol"},{"key":"1334_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jconrel.2018.11.003","volume":"292","author":"V Wilson","year":"2018","unstructured":"Wilson V, Lou X, Osterling DJ, Stolarik DF, Jenkins G, Gao W, et al. Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport. J Control Release. 2018;292:172\u201382.","journal-title":"J Control Release"},{"key":"1334_CR47","doi-asserted-by":"crossref","unstructured":"Kumar R, Sirvi A, Kaur S, Samal SK, Roy S, Sangamwar AT. Polymeric micelles based on amphiphilic oleic acid modified carboxymethyl chitosan for oral drug delivery of BCS class IV compound: intestinal permeability and pharmacokinetic evaluation. Eur J Pharm Sci. Elsevier B.V.; 2020;105466.","DOI":"10.1016\/j.ejps.2020.105466"},{"key":"1334_CR48","doi-asserted-by":"crossref","unstructured":"Narula A, Sabra R, Li N. Mechanisms and extent of enhanced passive permeation by colloidal drug particles. Mol Pharmaceutics. American Chemical Society; 2022;19:3085\u201399.","DOI":"10.1021\/acs.molpharmaceut.2c00124"},{"key":"1334_CR49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.biopha.2014.12.028","volume":"69","author":"Q Xiang","year":"2015","unstructured":"Xiang Q. Soluplus 1 micelles as a potential drug delivery system for reversal of resistant tumor. Biomed Pharmacother. 2015;69:388\u201395.","journal-title":"Biomed Pharmacother"},{"key":"1334_CR50","doi-asserted-by":"crossref","unstructured":"Kou L, Sun R, Bhutia YD, Yao Q, Chen R. Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery. Expert Opin Drug Deliv. Taylor & Francis; 2018;15:869\u201379.","DOI":"10.1080\/17425247.2018.1517749"},{"key":"1334_CR51","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1023\/A:1019829622088","volume":"19","author":"L Jia","year":"2002","unstructured":"Jia L, Wong H, Cerna C, Weitman SD. Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography \/ mass spectrometry. AAPS Pharm Res. 2002;19:1091\u20136.","journal-title":"AAPS Pharm Res"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01334-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:09:00Z","timestamp":1693390140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01334-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"16 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal handling, care, and experiments are carried out in compliance with ARRIVE guidelines and were carried out in accordance with the UK Animals (Scientific Procedures) Act, 1986, associated guidelines and EU Directive 2010\/63\/EU for animal experiments. The protocol mandatory to conduct pharmacokinetic study on laboratory animals was approved by Institutional Animal Ethics Committee (IAEC, NIPER S.A.S. Nagar, India) with the Protocol approval number: IAEC\/22\/ 07.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Abhay T. Sangamwar, corresponding author for this research article, on behalf of all the other respected authors (Mahendra Chougule, Arvind Sirvi, Vanshul Saini, and Mahesh Kashyap) hereby affirms that this article is in original form and does not violate any copyright. This research article has not been published earlier, and not under consideration in any other journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}